vs

Side-by-side financial comparison of Connect Biopharma Holdings Ltd (CNTB) and Ostin Technology Group Co., Ltd. (OST). Click either name above to swap in a different company.

Connect Biopharma Holdings Ltd is the larger business by last-quarter revenue ($24.1M vs $20.8M, roughly 1.2× Ostin Technology Group Co., Ltd.). Connect Biopharma Holdings Ltd runs the higher net margin — 61.6% vs -24.8%, a 86.4% gap on every dollar of revenue.

Connect Biopharma Holdings Ltd is a clinical-stage global biopharmaceutical company dedicated to developing innovative targeted therapies for inflammatory, immunological and autoimmune diseases. Its core pipeline includes candidate treatments for asthma, atopic dermatitis and other conditions with high unmet medical needs, with main operations across the U.S., China and key global markets to deliver effective therapeutic solutions to patients.

Ostin Technology Group Co., Ltd. is a provider of display and interactive technology solutions. It develops and manufactures touch panels, interactive whiteboards and custom display modules, serving consumer electronics, education and commercial segments across Asia Pacific, North America and European markets.

CNTB vs OST — Head-to-Head

Bigger by revenue
CNTB
CNTB
1.2× larger
CNTB
$24.1M
$20.8M
OST
Higher net margin
CNTB
CNTB
86.4% more per $
CNTB
61.6%
-24.8%
OST

Income Statement — Q2 FY2024 vs Q2 FY2025

Metric
CNTB
CNTB
OST
OST
Revenue
$24.1M
$20.8M
Net Profit
$14.8M
$-5.2M
Gross Margin
9.1%
Operating Margin
56.6%
-23.4%
Net Margin
61.6%
-24.8%
Revenue YoY
39.2%
Net Profit YoY
148.7%
-11.6%
EPS (diluted)
$0.27
$-2.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNTB
CNTB
OST
OST
Q1 25
$20.8M
Q2 24
$24.1M
Q1 24
$15.0M
Q2 23
$0
Net Profit
CNTB
CNTB
OST
OST
Q1 25
$-5.2M
Q2 24
$14.8M
Q1 24
$-4.6M
Q2 23
$-30.5M
Gross Margin
CNTB
CNTB
OST
OST
Q1 25
9.1%
Q2 24
Q1 24
5.9%
Q2 23
Operating Margin
CNTB
CNTB
OST
OST
Q1 25
-23.4%
Q2 24
56.6%
Q1 24
-25.3%
Q2 23
Net Margin
CNTB
CNTB
OST
OST
Q1 25
-24.8%
Q2 24
61.6%
Q1 24
-31.0%
Q2 23
EPS (diluted)
CNTB
CNTB
OST
OST
Q1 25
$-2.98
Q2 24
$0.27
Q1 24
$-0.29
Q2 23
$-0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNTB
CNTB
OST
OST
Cash + ST InvestmentsLiquidity on hand
$110.2M
$1.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$110.9M
$2.7M
Total Assets
$120.6M
$52.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNTB
CNTB
OST
OST
Q1 25
$1.7M
Q2 24
$110.2M
Q1 24
$1.7M
Q2 23
$81.6M
Stockholders' Equity
CNTB
CNTB
OST
OST
Q1 25
$2.7M
Q2 24
$110.9M
Q1 24
$10.3M
Q2 23
$128.7M
Total Assets
CNTB
CNTB
OST
OST
Q1 25
$52.6M
Q2 24
$120.6M
Q1 24
$51.4M
Q2 23
$144.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNTB
CNTB
OST
OST
Operating Cash FlowLast quarter
$-8.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.54×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNTB
CNTB
OST
OST
Q1 25
Q2 24
$-8.0M
Q1 24
$-3.9M
Q2 23
$-31.2M
Free Cash Flow
CNTB
CNTB
OST
OST
Q1 25
Q2 24
Q1 24
$-4.5M
Q2 23
FCF Margin
CNTB
CNTB
OST
OST
Q1 25
Q2 24
Q1 24
-30.1%
Q2 23
Capex Intensity
CNTB
CNTB
OST
OST
Q1 25
Q2 24
Q1 24
4.1%
Q2 23
Cash Conversion
CNTB
CNTB
OST
OST
Q1 25
Q2 24
-0.54×
Q1 24
Q2 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons